 |
Valrubicin |
|---|---|
| Trade Name | Valstar |
| Orphan Indication | Carcinoma in situ of the urinary bladder |
| USA Market Approval | USA |
| USA Designation Date | 1994-05-23 00:00:00 |
| Sponsor | Anthra Pharmaceuticals, Inc.;103 Carnegie Center, Suite 102;Princeton, New Jersey, 08540 |
